Jeffrey is Chief Scientific Officer at Sensorium. A seasoned biotech leader with deep experience in preclinical and IND-enabling research, Jeffrey has worked across multiple therapeutic areas, including neuropsychiatry, neurodegeneration, neuromuscular, and metabolic diseases. Throughout his career, Jeffrey has built several drug discovery platforms focused on small molecules and nucleic acid-based therapeutics across multiple organizations, including Bristol-Myers Squibb, Alexion, Voyager Therapeutics, Wave Life Sciences, and Deep Genomics. Jeffrey received a Ph.D. in Pharmacology and Toxicology from the University of Utah and an eMBA from Suffolk University. Following his Ph.D., Jeffrey completed post-doctoral training at Harvard Medical School and Boston University Medical Center. Combining his drug discovery experience with his passion for helping patients, Jeffrey founded Scientific Foundation LLC, an organization dedicated to helping families, patients, and biotech start-ups navigate the challenges of preclinical drug development.